We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACX
6751
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
-1,367
Closed -$13K
USER
6752
DELISTED
UserTesting, Inc.
USER
-492
Closed -$4K
POWRU
6753
DELISTED
Powered Brands Units
POWRU
-5
Closed
PACXU
6754
DELISTED
Pioneer Merger Corp. Unit
PACXU
-111
Closed -$1K
SWIR
6755
DELISTED
Sierra Wireless
SWIR
-4,043
Closed -$117K
IMGO
6756
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
-3,493
Closed -$125K
IGACU
6757
DELISTED
IG Acquisition Corp. Unit
IGACU
-183
Closed -$2K
IGAC
6758
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
-1,734
Closed -$17K
STAB
6759
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
-29,967
Closed -$2K
PKBO
6760
DELISTED
Peak Bio, Inc. Common Stock
PKBO
-3,161
Closed -$14K
DRAYU
6761
DELISTED
Macondray Capital Acquisition Corp. I Unit
DRAYU
-500
Closed -$5K
BRMK.WS
6762
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$0 ﹤0.01%
903
+9
+1%
POSH
6763
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
-12,593
Closed -$225K
GLS.WS
6764
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$0 ﹤0.01%
107
SPNE
6765
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-1,215
Closed -$11K
CZOO.WS
6766
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
$0 ﹤0.01%
200
OYST
6767
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-8,861
Closed -$99K
LJAQ
6768
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
-317
Closed -$4K
KAIR
6769
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
-300
Closed -$3K
EMCF
6770
DELISTED
Emclaire Financial Corp
EMCF
-361
Closed -$11K
CORZ
6771
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$0 ﹤0.01%
90
-189,078
-100%
LJAQU
6772
DELISTED
LightJump Acquisition Corporation Unit
LJAQU
-58
Closed -$1K
PCSB
6773
DELISTED
PCSB Financial Corporation
PCSB
-2,068
Closed -$40K
MDH.U
6774
DELISTED
MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant
MDH.U
-186
Closed -$2K
AATC
6775
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
-8,620
Closed -$31K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.